At the Center for Psychedelic Policy, we’re building the roadmap for affordable, state-funded access to psychedelic therapy. We advise legislators, regulators, and funders nationwide on pragmatic pilot programs and policy frameworks that expand access to care.
With over 16 years of experience shaping drug policy reform at the local, state, and national levels, our team has been at the forefront of launching and improving the nation’s first state-regulated psilocybin therapy programs. From leading Oregon’s Measure 109 campaign to supporting implementation efforts in Colorado and beyond, we bring deep expertise in designing safe, equitable, and effective psychedelic programs.
Through CPP, we help decision-makers across the country navigate affordability challenges and identify opportunities to integrate psychedelic-assisted care into existing behavioral health systems. Over the past five years, we’ve shared our insights with legislators, funders, and advocates through 150+ presentations and strategy sessions, supporting six- and seven-figure investments to advance access to care.
If you’re a policymaker, advocate, or funder interested in scaling affordable psychedelic healing, we’d love to connect.
Company Details
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- http://www.cppolicy.org
Center For Psychedelic Policy Questions
Center For Psychedelic Policy's website is http://www.cppolicy.org
Center For Psychedelic Policy's LinkedIn profile is https://www.linkedin.com/company/cppolicy
Center For Psychedelic Policy's industry is
Mental Health Care
Center For Psychedelic Policy's top competitors are
Psypost,
Talking Joints Memo,
Heroic Hearts Project,
Massachusetts Psychiatric Society.
Center For Psychedelic Policy's categories are Mental Health Care
